US 10428159
Blocking monoclonal antibodies to AGR2 and its receptor C4.4A
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 10428159 (Blocking monoclonal antibodies to AGR2 and its receptor C4.4A) held by The Board of Regents of the University of Texas System expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K39/3955, A61K39/39558